Inflammatory bowel disease therapeutic strategies by modulation of the microbiota: how and when to introduce pre-, pro-, syn-, or postbiotics? - Archive ouverte HAL Access content directly
Journal Articles AJP - Gastrointestinal and Liver Physiology Year : 2022

Inflammatory bowel disease therapeutic strategies by modulation of the microbiota: how and when to introduce pre-, pro-, syn-, or postbiotics?

(1) , (1, 2) , (1) , (3) , (2) , (1)
1
2
3

Abstract

Inflammatory bowel diseases (IBD), a heterogeneous group of inflammatory conditions that encompass both ulcerative colitis and Crohn’s disease, represent a major public health concern. The etiology of IBD is not yet fully understood and no cure is available, with current treatments only showing long-term effectiveness in a minority of patients. A need to increase our knowledge on IBD pathophysiology is growing, to define preventive measures, to improve disease outcome, and to develop new effective and lasting treatments. IBD pathogenesis is sustained by aberrant immune responses, associated with alterations of the intestinal epithelial barrier (IEB), modifications of the enteric nervous system, and changes in microbiota composition. Currently, most of the treatments target the inflammation and the immune system, but holistic approaches targeting lifestyle and diet improvements are emerging. As dysbiosis is involved in IBD pathogenesis, pre-, pro-, syn-, and postbiotics are used/tested to reduce the inflammation or strengthen the IEB. The present review will resume these works, pointing out the stage of life, the duration, and the environmental conditions that should go along with microbiota or microbiota-derived treatments.
Fichier principal
Vignette du fichier
Lê et al. - 2022 - Inflammatory bowel disease therapeutic strategies .pdf (1.41 Mo) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

hal-03871552 , version 1 (25-11-2022)

Licence

Attribution - CC BY 4.0

Identifiers

Cite

Amélie Lê, Marine Mantel, Justine Marchix, Marie Bodinier, Gwénaël Jan, et al.. Inflammatory bowel disease therapeutic strategies by modulation of the microbiota: how and when to introduce pre-, pro-, syn-, or postbiotics?. AJP - Gastrointestinal and Liver Physiology, 2022, 323 (6), pp.G523-G553. ⟨10.1152/ajpgi.00002.2022⟩. ⟨hal-03871552⟩
0 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More